Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. J.G.W. (Jos) Kosterink

Publicaties

Azithromycin as host-directed therapy for pulmonary tuberculosis - a randomized pilot trial: A Randomized Pilot Trial

Osimertinib Cost Minimization in Non-Small Cell Lung Cancer (NSCLC) Treatment: Hypothesis Generation for a Population Pharmacokinetic Approach for Equivalent Dose Optimization of Osimertinib in Combination With Cobicistat

Tacrolimus Trough Concentrations are Not Impacted by Epstein–Barr Virus Serology and Viral Load in Pediatric Liver Transplant Recipients

Validation of a LC-MS/MS Assay for Rapid and Simultaneous Quantification of Cobicistat and Venetoclax in Human Plasma and Serum

Venetoclax boosting in acute myeloid leukemia (aml): preliminary pharmacokinetic results from the hovon 171 trial

Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial

Zorgen om de beschikbaarheid van het olanzapinedepot in Nederland

Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease

Infliximab in paediatric inflammatory bowel disease: External evaluation of population pharmacokinetic models

Monoclonal antibody biosimilars for cancer treatment

Pers/media

Besparingen door effectiever voorschrijven medicijnen

Campagne Wemos over medicijnprijzen lanceert Monopoly, de Medicijn Editie

Hoe een Gronings ziekenhuis het opneemt tegen big pharma

In het lab werkte de medicatie. Maar de echte wereld is geen lab

Nationaal Groeifonds investeert in UMCG-studies om ontwikkeling kankermedicijnen te versnellen

UMCG gaat strijd aan tegen geneesmiddelkaping door farmaceuten

Waarom pillen steeds beter werken (Dagblad van het Noorden)

Interview zorg instituut Nederland